ARCA biopharma

company

About

ARCA biopharma develops genetically-targeted therapies for cardiovascular diseases.

  • 11 - 50

Details

Last Funding Type
Series B
Last Funding Money Raised
$18M
Industries
Biotechnology,Genetics,Medical,Therapeutics
Founded date
Jan 1, 1992
Number Of Employee
11 - 50
Operating Status
Active

ARCA biopharma, Inc. is a Colorado-based biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases.

ARCA’s principal focus is to develop personalized therapies for the treatment of cardiovascular disease through the use of genetics. The Company’s business focus combines expertise in cardiovascular pathophysiology, molecular genetics and clinical development.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$18M
ARCA biopharma has raised a total of $18M in funding over 2 rounds. Their latest funding was raised on Jun 12, 2007 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 12, 2007 Series B $18M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
ARCA biopharma is funded by 1 investors. The Peierls Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
The Peierls Foundation Series B